JAPC - X-Ray CT Imaging as a Biomarker for Lung Cancer

Speaker: Dr. Michael McNitt-Gray, David Geffen School of Medicine, University of California, Los Angeles

Topic: "X-Ray CT Imaging as a Biomarker for Lung Cancer: Detection, Characterization and Evaluation of Treatment"

Time: 2:00 PM, Friday, November 21st, 2008

Place: P-148 (refreshments will be served at 1:45 PM in P145A)

Abstract: Lung Cancer is the leading cancer killer, responsible for more cancer deaths than the next three cancers combined; also, more women die from lung cancer than from breast cancer each year. Successful treatment options have made little progress, with lung cancer death rates staying nearly constant over the last several decades. This seminar will discuss recent technical advances in x-ray CT imaging and the implications for its role in the early detection and diagnosis of lung cancer as well as recent interest in the use of CT imaging as a biomarker for the disease. In this last application, CT may be used to accurately and rapidly assess the response of patients to therapeutic agents. In combination with contrast agents and/or other modalities, the results of CT imaging may provide insight into not just changes in anatomic structure (did the tumor grow or not), but also into function (is the tumor still active).

You can view JAPC upcoming talks or the archive.